Evidence map›Paper›PMID 36717406›Full record

ArticleDiabetologia2023

Determination of autoantibodies in type 2 diabetes: one simple way to improve classification. Reply by Laferrère to Ludvigsson J [letter].

Blandine Laferrère

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Blandine LaferrèreDivision of Endocrinology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. BBL14@columbia.edu.ORCID https://orcid.org/0000-0001-8255-3175

Funding

Clinical and Translational Science AwardUL1TR001873 · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2025 to 2025
$10.0M
Translational Biomarker Analytical Core (TBAC)P30DK063608 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2003 to 2025
$8.5M
RESEARCH TRAININGP30DK026687 · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · 1986 to 2025
$7.5M
Mechanisms of Diabetes Control After Weight Loss SurgeryR01DK067561 · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · 2005 to 2005
$404k
NCATS NIH HHS UL1 TR000040NCATS NIH HHS UL1 TR001873NIDDK NIH HHS F32 DK113747NIDDK NIH HHS P30 DK026687NIDDK NIH HHS P30 DK063608NIDDK NIH HHS R01 DK067561NIDDK NIH HHS R01 DK098056NIDDK NIH HHS R01 DK108580
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bariatric SurgeryDiabetes Mellitus, Type 2AutoantibodiesHumansObesityRemission InductionTreatment OutcomeAutoantibodiesAutoimmunityBariatric surgeryDiabetes relapseDiabetes remission

Identifiers

PMID36717406
PMCPMC11374121

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.